357831656	357831656	CD	B-NP	O
|	|	NN	I-NP	O
HSUMC	HSUMC	NN	I-NP	O
|	|	NN	I-NP	O
59535642	59535642	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8891553	8891553	CD	B-NP	O
|	|	CC	I-NP	O
2/12/2002	2/12/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
noncardiac	noncardiac	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
possible	possible	JJ	B-NP	O
GERD	GERD	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/18/2002	1/18/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2002	10/10/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
SEACREST	SEACREST	NNP	B-NP	O
,	,	,	O	O
LEON	LEON	NNP	B-NP	O
431-35-84-8	431-35-84-8	CD	I-NP	O
Denceker	Denceker	NNP	I-NP	O
Ville	Ville	NNP	I-NP	O
York	York	NNP	I-NP	O
Eo	Eo	NNP	I-NP	O
Age	Age	NNP	I-NP	O
,	,	,	O	O
Nevada	Nevada	NNP	B-NP	O
70245	70245	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
9/19/02	9/19/02	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BRANDAU	BRANDAU	NNP	B-NP	O
,	,	,	O	O
HARRIS	HARRIS	NNP	B-NP	O
KELLEY	KELLEY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
VENTOLIN	VENTOLIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
INHALER	INHALER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
BERGUM	BERGUM	NNP	B-NP	O
,	,	,	O	O
DAVID	DAVID	NNP	B-NP	O
ZACHARIAH	ZACHARIAH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
TID	TID	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
38319803	38319803	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
RUSSAK	RUSSAK	NNP	B-NP	O
,	,	,	O	O
SON	SON	NNP	B-NP	O
SAMUEL	SAMUEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
19011645	19011645	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
RADLINSKI	RADLINSKI	NN	B-NP	O
,	,	,	O	O
MAX	MAX	NNP	B-NP	O
BRADY	BRADY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
QHS	QHS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
14945298	14945298	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
GITTING	GITTING	NNP	B-NP	O
,	,	,	O	O
PETER	PETER	NNP	B-NP	O
MALIK	MALIK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
CYCLOBENZAPRINE	CYCLOBENZAPRINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
SUSTAINED	SUSTAINED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	B-protein
120	120	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
TEO	TEO	NNP	B-NP	O
,	,	,	O	O
MILTON	MILTON	NNP	B-NP	O
SHELTON	SHELTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
62059406	62059406	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
HAUSKINS	HAUSKINS	NN	B-NP	O
,	,	,	O	O
PAUL	PAUL	NNP	B-NP	O
CLINTON	CLINTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
47943900	47943900	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
FOLATE	FOLATE	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
FALLEY	FALLEY	NNP	B-NP	O
,	,	,	O	O
LUTHER	LUTHER	NNP	B-NP	O
JACKIE	JACKIE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
REEGER	REEGER	NNP	B-NP	O
,	,	,	O	O
ANTONE	ANTONE	NNP	B-NP	O
JOHNATHON	JOHNATHON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/8	7/8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
KLOSKY	KLOSKY	NNP	B-NP	O
,	,	,	O	O
ANGELO	ANGELO	NNP	B-NP	O
MATTHEW	MATTHEW	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
00230663	00230663	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
X	X	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Follow	Follow	NNP	I-NP	O
manufacturer	manufacturer	NN	I-NP	O
's	's	POS	B-NP	O
info	info	NN	I-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
HOLLERMAN	HOLLERMAN	NN	B-NP	O
,	,	,	O	O
GALE	GALE	NNP	B-NP	O
ERROL	ERROL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
QHS	QHS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
14945298	14945298	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
REINTS	REINTS	NNP	B-NP	O
,	,	,	O	O
GLEN	GLEN	NNP	B-NP	O
SANDY	SANDY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
HYLES	HYLES	NNP	B-NP	O
,	,	,	O	O
RANDY	RANDY	NNP	B-NP	O
ARLIE	ARLIE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
MVI	MVI	NNP	B-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
W/MINERALS	W/MINERALS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
THERAP	THERAP	NN	I-NP	O
VITS/MINERALS	VITS/MINERALS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6.5	6.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/8	7/8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
WINNEGAN	WINNEGAN	NNP	B-NP	O
,	,	,	O	O
FREDDIE	FREDDIE	NNP	B-NP	O
RODGER	RODGER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
Override	Override	NN	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
MCCRACKEN	MCCRACKEN	NNP	B-NP	O
,	,	,	O	O
ANGELO	ANGELO	NNP	B-NP	O
CORTEZ	CORTEZ	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
TID	TID	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
38319803	38319803	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
WRY	WRY	NNP	B-NP	O
,	,	,	O	O
DOUG	DOUG	NNP	B-NP	O
ABRAM	ABRAM	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ECASA	ECASA	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
21466482	21466482	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
WITZKE	WITZKE	NNP	B-NP	O
,	,	,	O	O
EFREN	EFREN	NNP	B-NP	O
SID	SID	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
19011645	19011645	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
SEREVENT	SEREVENT	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SALMETEROL	SALMETEROL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
BID	BID	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
OWH	OWH	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/1/02	6/1/02	CD	B-NP	O
by	by	IN	B-PP	O
VALOT	VALOT	NNP	B-NP	O
,	,	,	O	O
MAURICIO	MAURICIO	NNP	B-NP	O
REY	REY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
FLOVENT	FLOVENT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
880	880	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Immediately	Immediately	RB	B-ADVP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Primary	Primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Inderal	Inderal	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
beta-blockers	beta-blocker	NNS	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Quintrim	Quintrim	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
r/o	r/o	NNP	B-NP	O
MI	MI	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
noncardiac	noncardiac	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
GERD	GERD	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
ASTHMA	ASTHMA	NNP	I-NP	O
HTN	HTN	NN	I-NP	O
OSTEONECROSIS	OSTEONECROSIS	NNP	I-NP	O
HIPS	HIPS	NNP	I-NP	O
W	W	NNP	I-NP	O
/	/	SYM	B-NP	O
REPL	REPL	NN	I-NP	O
.	.	.	O	O

GOUT	GOUT	NN	B-NP	B-protein
DIVERTICULITIS	DIVERTICULITIS	NN	I-NP	I-protein
LEUKOPLAKIA	LEUKOPLAKIA	NN	I-NP	I-protein
cardiomyopathy	cardiomyopathy	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
?	?	.	O	O

etiology	etiology	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
?	?	.	O	O

angina	angina	NN	B-NP	O
nevi	nevus	NNS	I-NP	O
excised	excise	VBN	B-VP	O
from	from	IN	B-PP	O
legs	leg	NNS	B-NP	O
EF	EF	NN	I-NP	O
30-40	30-40	CD	B-NP	O
%	%	NN	I-NP	O
h/o	h/o	NN	I-NP	O
EtOH	EtOH	NN	I-NP	O
abuse	abuse	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
alcohol	alcohol	NN	I-NP	O
abuse	abuse	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
LV	LV	NN	I-NP	O
thrombus	thrombus	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
AVN	AVN	NN	I-NP	O
R	R	NN	I-NP	O
elbow	elbow	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
avascular	avascular	JJ	I-NP	O
necrosis	necrosis	NN	I-NP	O
femoral	femoral	JJ	I-NP	O
head	head	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PVD	PVD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
Trigeminy	Trigeminy	NNP	I-NP	O
OPERATIONS	OPERATIONS	NNP	I-NP	O
AND	AND	CC	O	O
PROCEDURES	PROCEDURES	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
53M	53M	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NN	I-NP	O
1995	1995	CD	I-NP	O
,	,	,	O	O
CMP	CMP	NN	B-NP	O
EF	EF	NN	I-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
heavy	heavy	JJ	I-NP	O
EtOH	EtOH	NN	I-NP	O
use	use	NN	I-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
waxing	wax	VBG	B-VP	O
and	and	CC	I-VP	O
waning	wan	VBG	I-VP	O
``	``	``	O	O
crushing	crush	VBG	B-VP	O
substernal	substernal	JJ	B-NP	O
CP	CP	NN	I-NP	O
''	''	''	O	O
2/10	2/10	CD	B-NP	O
-8	-8	CD	I-NP	O
/	/	SYM	B-NP	O
10	10	CD	I-NP	O
lasting	last	VBG	I-NP	O
minutes	minute	NNS	I-NP	O
to	to	TO	B-PP	O
hours	hour	NNS	B-NP	O
,	,	,	O	O
radiating	radiate	VBG	B-VP	O
to	to	TO	I-VP	O
back	back	VB	I-VP	O
,	,	,	O	O
without	without	IN	B-PP	O
associated	associate	VBN	B-NP	O
sx	sx	NN	I-NP	O
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
some	some	DT	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
NOT	NOT	NN	B-NP	B-protein
like	like	IN	B-PP	O
previous	previous	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

Not	Not	RB	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
otherwise	otherwise	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

sleeps	sleep	NNS	B-NP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
pillows	pillow	NNS	I-NP	O
for	for	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hip	hip	NN	I-NP	O
pain	pain	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
PND/LE	PND/LE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Admits	Admit	NNS	B-NP	O
to	to	TO	B-PP	O
drinking	drink	VBG	B-VP	O
6	6	CD	B-NP	O
beers/day	beers/day	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
also	also	RB	B-ADVP	O
sig	sig	NN	B-NP	B-protein
for	for	IN	B-PP	O
COPD/asthma	COPD/asthma	NN	B-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
hip	hip	NN	I-NP	O
replacements	replacement	NNS	I-NP	O
,	,	,	O	O
LV	LV	NN	B-NP	O
thrombus	thrombus	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	VBN	B-NP	O
88157/97	88157/97	CD	I-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
NC	NC	NN	I-NP	O
exam	exam	NN	I-NP	O
sig	sig	NN	I-NP	O
for	for	IN	B-PP	O
JVP	JVP	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
cm	cm	NN	I-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
S1/S2	S1/S2	NN	I-NP	I-protein
+	+	SYM	B-NP	O
S4	S4	NN	I-NP	B-protein
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

CTAB	CTAB	NN	B-NP	B-protein
.	.	.	O	O

Abd	Abd	NNP	B-NP	O
obese	obese	JJ	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
HSM	HSM	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
pulses	pulse	VBZ	B-VP	O
EKG	EKG	NN	B-NP	O
NSR	NSR	NN	I-NP	O
78	78	CD	I-NP	O
bpm	bpm	NN	I-NP	O
LAD	LAD	NN	I-NP	O
?	?	.	O	O

LAFB	LAFB	NN	B-NP	B-protein
labs	lab	VBZ	B-VP	O
sig	sig	NN	B-NP	B-protein
for	for	IN	B-PP	O
CK	CK	NN	B-NP	B-protein
167	167	CD	I-NP	I-protein
TnI	TnI	NN	I-NP	I-protein
0.05	0.05	CD	B-NP	I-protein
BNP	BNP	NN	I-NP	I-protein
21	21	CD	B-NP	I-protein
.	.	.	O	O

WBC	WBC	NNP	B-NP	B-protein
5	5	CD	I-NP	I-protein
HCt	HCt	NNP	I-NP	O
43	43	CD	I-NP	O
Plt	Plt	NNP	I-NP	O
88	88	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
low	low	JJ	B-ADJP	O
in	in	IN	B-PP	O
past	past	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
1.8	1.8	CD	I-NP	O
.	.	.	O	O

#	#	#	B-NP	O
#	#	#	I-NP	O
CV	CV	NN	I-NP	O
-	-	HYPH	O	O
completed	complete	VBN	B-NP	O
r/o	r/o	NN	I-NP	O
by	by	IN	B-PP	O
enzymes/EKG	enzymes/EKG	NN	B-NP	B-protein
x3	x3	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
cont	cont	NN	I-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
;	;	:	O	O
apparently	apparently	RB	B-ADJP	O
intolerant	intolerant	JJ	I-ADJP	O
of	of	IN	B-PP	O
beta-blockers	beta-blocker	NNS	B-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
.	.	.	O	O

BP	BP	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
by	by	IN	B-PP	O
hx	hx	NN	B-NP	O
or	or	CC	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
4/6	4/6	CD	I-NP	O
max	max	NN	I-NP	O
HR	HR	NN	I-NP	O
127	127	CD	I-NP	O
,	,	,	O	O
double	double	JJ	B-NP	O
product	product	NN	I-NP	O
23K	23K	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Moderately	Moderately	RB	B-NP	O
dilated	dilate	VBN	I-NP	O
LV	LV	NN	I-NP	O
,	,	,	O	O
severely	severely	RB	B-NP	O
dilated	dilated	JJ	I-NP	O
RV	RV	NN	I-NP	O
,	,	,	O	O
LVEF	LVEF	NN	B-NP	O
51	51	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Fixed	Fix	VBN	B-NP	O
severe	severe	JJ	I-NP	O
inferobasal	inferobasal	JJ	I-NP	O
defect	defect	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
HK	HK	NN	I-NP	O
c/w	c/w	NN	I-NP	O
prior	prior	JJ	I-NP	O
PDA	PDA	NN	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

#	#	#	B-NP	O
#	#	#	I-NP	O
Heme	Heme	NN	I-NP	B-protein
-	-	HYPH	O	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
but	but	CC	O	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
repeat	repeat	NN	B-NP	O
CBC	CBC	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
coumadin	coumadin	NN	I-NP	O
for	for	IN	B-PP	O
LV	LV	NN	B-NP	B-protein
thrombus	thrombus	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
#	#	#	I-NP	I-protein
GI	GI	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
antacids	antacid	NNS	I-NP	O
,	,	,	O	O
PPI	PPI	NN	B-NP	B-protein
.	.	.	O	O

Patient	Patient	NN	B-NP	O
reports	report	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
relief	relief	NN	I-NP	O
of	of	IN	B-PP	O
GERD	GERD	NN	B-NP	B-protein
sx	sx	NN	I-NP	I-protein
with	with	IN	B-PP	O
PPI	PPI	NN	B-NP	B-protein
.	.	.	O	O

Will	Will	MD	B-VP	O
discharge	discharge	VB	I-VP	O
with	with	IN	B-PP	O
trial	trial	NN	B-NP	O
of	of	IN	B-PP	O
PPI	PPI	NN	B-NP	B-protein
;	;	:	O	O
possible	possible	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
GERD/dyspepsia	GERD/dyspepsia	NNP	B-NP	O
.	.	.	O	O

#	#	#	B-NP	O
#	#	#	I-NP	O
EtOH	EtOH	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
prophylactic	prophylactic	JJ	I-NP	O
lorazepam	lorazepam	NN	I-NP	O
given	give	VBN	B-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
withdrawal	withdrawal	NN	B-NP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
counseled	counsel	VBN	B-VP	O
on	on	IN	B-PP	O
EtOH	EtOH	NN	B-NP	O
abstinence/reduction	abstinence/reduction	NN	I-NP	O
.	.	.	O	O

#	#	#	B-NP	O
#	#	#	I-NP	O
pulm	pulm	NN	I-NP	O
-	-	HYPH	I-NP	O
cont	cont	NN	I-NP	O
COPD	COPD	NN	I-NP	O
meds	med	NNS	I-NP	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
return	return	VB	B-VP	O
to	to	TO	I-VP	O
ED	ED	VB	I-VP	O
or	or	CC	I-VP	O
call	call	VB	I-VP	O
911	911	CD	B-NP	O
for	for	IN	B-PP	O
crushing	crush	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
tablets	tablet	NNS	I-NP	O
and	and	CC	O	O
lasts	last	VBZ	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
20	20	CD	I-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
recheck	recheck	VB	B-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
level	level	NN	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BAELL	BAELL	NNP	B-NP	O
,	,	,	O	O
KENNITH	KENNITH	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
XR03	XR03	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/19/02	9/19/02	CD	I-NP	O
@	@	SYM	B-NP	O
06	06	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

